ALT FY 2018 Earnings — Altimmune, Inc. Revenue & Financial Results | Market Cap Arena

ALTAltimmune, Inc.

$331M

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$10M+24792.6% YoY

Gross Profit

-$8M-78.7% margin

Operating Income

-$43M-414.6% margin

Net Income

-$39M-379.2% margin

EPS (Diluted)

$-13.98

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$10M

Stock-Based Comp.

$773,248

Balance Sheet

Total Assets

$55M

Total Liabilities

$6M

Stockholders' Equity

$48M

Cash & Equivalents

$34M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$10M	$41,503	+24792.6%
Gross Profit	-$8M	-$18M	+55.7%
Operating Income	-$43M	-$52M	+17.7%
Net Income	-$39M	-$46M	+15.6%